Peter Pisters, President at MD Anderson Cancer Center, shared a post on LinkedIn:
“Pleased to join the first Institute for Cell Therapy Discovery and Innovation’s External Advisory Board meeting. With their support and expertise, MD Anderson Cancer Center is well-positioned to translate scientific breakthroughs into powerful cell-based treatments more efficiently, at lower cost, with less toxicity and with greater convenience for patients.”
More posts featuring Peter Pisters on OncoDaily.